Sucampo Pharma Prices Low

Sucampo Pharmaceuticals Inc., a Bethesda, Md.-based drug company working with a class of compounds known as prostones, raised $43.13 million through its IPO. The company priced 3.75 million Class A common shares at $11.50 per share ($14-$16 range). It will trade on the Nasdaq under ticker symbol SCMP, while Cowen & Co. served as co-lead underwriters. Shareholders include Fujisawa Pharmaceutical Co. Ltd., Orix Corp., Mitsubishi UFJ Capital Co., Tokyo Marine and Nichido Fire Insurance Co., Mizuho Capital and Astellas Pharma Inc. www.sucampo.com